Estrella Immunopharma, Inc. (ESLA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 57.44M |
| Enterprise Value | 56.06M |
| P/E Ratio | -1.84 |
| PEG Ratio | -0.1 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -2.63 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -2 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -5.49 |
| Return On Equity | 1.22 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -13.06M |
| Net Income | -13.06M |
| Diluted EPS | -0.35 |
| Total Cash | 146,670 |
| Total Cash/Share | 0 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0.2 |
| Book Value Per Share | -0.17 |
| 52-Week Change | -71.82 |
| 52-Week High | 3.15 |
| 52-Week Low | 0.3 |
| Moving Average 50 Days | 0.59 |
| Moving Average 200 Days | 1.02 |
| Average Volume | 1.34M |
| Shares Outstanding | 43.5M |
| % Held by Institutions | 11.15 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |